TG Therapeutics Inc (TGTX)
16.48
-0.94
(-5.40%)
USD |
NASDAQ |
May 17, 16:00
16.48
0.00 (0.00%)
After-Hours: 20:00
TG Therapeutics Cash from Operations (Quarterly): -8.207M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -8.207M |
| December 31, 2023 | -13.21M |
| September 30, 2023 | 83.70M |
| June 30, 2023 | -42.00M |
| March 31, 2023 | -59.90M |
| December 31, 2022 | -23.87M |
| September 30, 2022 | -34.50M |
| June 30, 2022 | -49.12M |
| March 31, 2022 | -68.69M |
| December 31, 2021 | -86.91M |
| September 30, 2021 | -67.20M |
| June 30, 2021 | -60.17M |
| March 31, 2021 | -81.36M |
| December 31, 2020 | -52.03M |
| September 30, 2020 | -56.53M |
| June 30, 2020 | -43.83M |
| March 31, 2020 | -62.12M |
| December 31, 2019 | -30.39M |
| September 30, 2019 | -33.20M |
| June 30, 2019 | -35.86M |
| March 31, 2019 | -33.35M |
| December 31, 2018 | -33.69M |
| September 30, 2018 | -33.01M |
| June 30, 2018 | -34.18M |
| March 31, 2018 | -28.04M |
| Date | Value |
|---|---|
| December 31, 2017 | -21.86M |
| September 30, 2017 | -22.78M |
| June 30, 2017 | -26.83M |
| March 31, 2017 | -22.30M |
| December 31, 2016 | -17.02M |
| September 30, 2016 | -15.04M |
| June 30, 2016 | -12.85M |
| March 31, 2016 | -16.67M |
| December 31, 2015 | -12.90M |
| September 30, 2015 | -10.66M |
| June 30, 2015 | -12.25M |
| March 31, 2015 | -8.882M |
| December 31, 2014 | -15.11M |
| September 30, 2014 | -8.051M |
| June 30, 2014 | -3.573M |
| March 31, 2014 | -8.329M |
| December 31, 2013 | -4.824M |
| September 30, 2013 | -1.154M |
| June 30, 2013 | -2.556M |
| March 31, 2013 | -2.205M |
| December 31, 2012 | -0.8333M |
| September 30, 2012 | -2.993M |
| June 30, 2012 | -0.4998M |
| March 31, 2012 | -0.8616M |
| December 31, 2011 | -0.0565M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-86.91M
Minimum
Dec 2021
83.70M
Maximum
Sep 2023
-41.27M
Average
-46.48M
Median
Cash from Operations (Quarterly) Benchmarks
| Amicus Therapeutics Inc | -29.70M |
| Geron Corp | -62.25M |
| Editas Medicine Inc | -49.87M |
| G1 Therapeutics Inc | -8.898M |
| Mersana Therapeutics Inc | -32.66M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -9.255M |
| Cash from Financing (Quarterly) | 0.01M |
| Free Cash Flow | 20.28M |
| Free Cash Flow Per Share (Quarterly) | -0.0561 |
| Free Cash Flow to Equity (Quarterly) | -9.415M |
| Free Cash Flow to Firm (Quarterly) | -5.913M |
| Free Cash Flow Yield | 0.82% |